Stocks›Healthcare›INSM

INSM

INSMED INC

NasdaqResearch view

Healthcare · Pharmaceutical Preparations · Large-cap · SEC EDGAR FY 2025-12-31

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$26.2B

Enterprise Value$26.5B

Income$-1.3B

Sales$606.4M

Book/sh$3.38

Cash/sh$2.34

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio3.54

Current Ratio3.83

Debt/Eq1.04

EPS (ttm)$-6.42

EPS this Y-15.3%

EPS past 3/5Y—

Sales past 3/5Y35.2%

EPS Y/Y TTM-15.3%

Sales Y/Y TTM66.7%

Shs Outstand218.38M

ROA-56.4%

ROE-172.8%

ROIC-125.1%

Gross Margin—

Oper. Margin-205.6%

Profit Margin-210.5%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$188.5M

2021

$245.4M

2022

$305.2M

2023

$363.7M

2024

$606.4M

2025

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$188.5M	$245.4M	$305.2M	$363.7M	$606.4M
Gross Profit	—	—	—	—	—
Operating Income	$-375.1M	$-457.3M	$-709.6M	$-878.3M	$-1.2B
Net Income	$-434.7M	$-481.5M	$-749.6M	$-913.8M	$-1.3B
Diluted EPS	$-3.88	$-3.91	$-5.34	$-5.57	$-6.42
Operating Cash Flow	$-363.3M	$-400.4M	$-536.2M	$-683.9M	$-935.0M
Free Cash Flow	$-370.6M	$-410.3M	$-549.5M	$-705.8M	$-967.6M